EmTec Management offers genuine solutions to problems surrounding intellectual property rights (IPR) faced by the biotechnology industry in developing countries. We achieve this by creating an environment in which widely dispersed technology providers and end users are linked, allowing them to quickly identify relevant technologies and, through standardized procedures, to complete licensing transactions. In this way, an efficient global trading place for research methodology, applied technologies, genetic materials, and germplasm can be created. EmTec Management is squarely focused on the biotechnology sector and the specific needs of the research institutions and industries involved in this particular sector. Three fundamental functions are provided:

• The capacity to identify all relevant intellectual property rights that exist over a given technology and how it can be accessed.



• The establishment of a pricing scheme and terms for a contract framework for in- and out-licensing.



• An arbitration mechanism for monitoring and enforcing the contracts concluded.

A further service provided by EmTec Management is to maintain and provide data about the current regulatory approval and bio-safety status of new technologies. Keeping abreast of the value of these technologies, and determining a fair market price and terms for them, are crucially important for individuals in the biotechnology industry. It is also important for interested parties to be able to keep track of which components of the technology have been approved, for which uses, and in which countries. A key goal at EmTec, therefore, is to allow and encourage the participation of those currently excluded from the global marketplace to be able to:

• acquire these technologies at a reasonable cost and under reasonable terms



• develop their own technologies



• offer their own inventions for licensing

EmTec provides incentives to potential technology providers in developing countries to patent their inventions and discoveries so that they can be disseminated and so that the providers can earn royalties in the global marketplace setting.